Research

 Our research is dedicated to the innovation and enhancement of mitochondrial genome editing technologies. We focus on reducing off-target effects and enhancing precision to advance the field of genome editing.

We utilize mitochondrial editing technology in cells and artificial organs to simulate mitochondrial diseases. 

We can also generate and analyze animal models for mitochondrial diseases.

In our quest to combat diseases related to mitochondria, we are advancing the development of mitochondrial genome editing treatments. Our focus encompasses both genome therapy and cell therapy, aiming to offer effective solutions for these conditions.

Through the use of mitochondrial editing technology, we are exploring the functions of mitochondrial genes, as well as the mechanisms underlying mitochondrial genetics and dynamics. This research is pivotal in understanding the complex roles of mitochondria in cellular processes.